Exact Sciences
EXAS
#1384
Rank
C$17.75 B
Marketcap
$96.07
Share price
2.34%
Change (1 day)
-5.23%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$0.21 B

According to Exact Sciences's latest financial reports the company's current earnings (TTM) are -C$0.22 B. In 2023 the company made an earning of -C$0.26 B an increase over its 2022 earnings that were of -C$0.84 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.21 B-17.02%
2023 -C$0.26 B-69.98%
2022 -C$0.84 B-25.55%
2021 -C$1.13 B1.68%
2020 -C$1.11 B271.17%
2019 -C$0.3 B58.99%
2018 -C$0.19 B20.89%
2017 -C$0.16 B-30.95%
2016 -C$0.23 B5.09%
2015 -C$0.22 B57.24%
2014 -C$0.14 B116.53%
2013 -C$62.8 M
2011 -C$39.1 M143.73%
2010 -C$16.05 M27.85%
2009 -C$12.55 M0.27%
2008 -C$12.52 M-20.95%
2007 -C$15.83 M-13.53%
2006 -C$18.31 M-10.07%
2005 -C$20.36 M-21.81%
2004 -C$26.04 M-33.44%
2003 -C$39.12 M-6.51%
2002 -C$41.84 M17.95%
2001 -C$35.48 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.21 B-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$89.36 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$74.32 M-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$47.43 M-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.15 B-4,458.48%๐Ÿ‡ซ๐Ÿ‡ท France